I’m going to flip back to oral diabetes meds to cover a new agent that has recently been approved. It is a new class of diabetes med, but generally means it’s going to be quite expensive. This drug is Invokana (canagliflozin). It basically lowers glucose by causing an increase in excretion of glucose out of the body via means of the kidney/urine. Side effects – you may see an elevation in potassium levels in the body so this should be monitored for as well as kidney function. Because of the mechanism of this drug, an increase in urine glucose can be problematic for infections as bugs(bacteria etc.) tend to like glucose (sugar) – i.e. it helps them grow and flourish…so an increased risk of urinary infections may be possible as well with this med.
New Kid on the Diabetes Block
Written By Eric Christianson
November 27, 2013
Buy on Amazon
Free 18 Page PDF On The Most Notable Drug Interactions!
Looking for something?
- ARB Comparison Table
- BIG Change to the Real Life Pharmacology Podcast! Asthma Pharmacology Q&A With Clinical Pharmacist and Expert Beth Zerr, PharmD, BCACP
- Why Is Bexagliflozin The Cheapest SGLT-2 Inhibitor?
- ACE Inhibitor Comparison Table
- Medications That Cause Low Blood Pressure (Non-Antihypertensives)